These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 17985997)

  • 1. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches.
    Khan MT
    Curr Drug Metab; 2010 May; 11(4):285-95. PubMed ID: 20450477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
    Sanders JM; Beshore DC; Culberson JC; Fells JI; Imbriglio JE; Gunaydin H; Haidle AM; Labroli M; Mattioni BE; Sciammetta N; Shipe WD; Sheridan RP; Suen LM; Verras A; Walji A; Joshi EM; Bueters T
    J Med Chem; 2017 Aug; 60(16):6771-6780. PubMed ID: 28418656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward in silico structure-based ADMET prediction in drug discovery.
    Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA
    Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent uses of topological indices in the development of in silico ADMET models.
    Votano JR
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):32-7. PubMed ID: 15679169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving ADMET Prediction Accuracy for Candidate Drugs: Factors to Consider in QSPR Modeling Approaches.
    Chen M; Yang J; Tang C; Lu X; Wei Z; Liu Y; Yu P; Li H
    Curr Top Med Chem; 2024; 24(3):222-242. PubMed ID: 38083894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided Drug Design and Drug Pharmacokinetic Prediction: A Mini-review.
    Tabeshpour J; Sahebkar A; Zirak MR; Zeinali M; Hashemzaei M; Rakhshani S; Rakhshani S
    Curr Pharm Des; 2018; 24(26):3014-3019. PubMed ID: 30179125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery.
    Lin J; Sahakian DC; de Morais SM; Xu JJ; Polzer RJ; Winter SM
    Curr Top Med Chem; 2003; 3(10):1125-54. PubMed ID: 12769713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling ADMET.
    Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
    Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive assessment of ADMET risks in drug discovery.
    Wang J
    Curr Pharm Des; 2009; 15(19):2195-219. PubMed ID: 19601823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building predictive ADMET models for early decisions in drug discovery.
    Penzotti JE; Landrum GA; Putta S
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):49-61. PubMed ID: 14982148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADMET in silico modelling: towards prediction paradise?
    van de Waterbeemd H; Gifford E
    Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning approaches for predicting compounds that interact with therapeutic and ADMET related proteins.
    Li H; Yap CW; Ung CY; Xue Y; Li ZR; Han LY; Lin HH; Chen YZ
    J Pharm Sci; 2007 Nov; 96(11):2838-60. PubMed ID: 17786989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4D- quantitative structure-activity relationship modeling: making a comeback.
    Fourches D; Ash J
    Expert Opin Drug Discov; 2019 Dec; 14(12):1227-1235. PubMed ID: 31513441
    [No Abstract]   [Full Text] [Related]  

  • 15. The application of in silico drug-likeness predictions in pharmaceutical research.
    Tian S; Wang J; Li Y; Li D; Xu L; Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine Learning for In Silico ADMET Prediction.
    Jia L; Gao H
    Methods Mol Biol; 2022; 2390():447-460. PubMed ID: 34731482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaussian processes: a method for automatic QSAR modeling of ADME properties.
    Obrezanova O; Csanyi G; Gola JM; Segall MD
    J Chem Inf Model; 2007; 47(5):1847-57. PubMed ID: 17602549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments of in silico predictions of intestinal absorption and oral bioavailability.
    Hou T; Li Y; Zhang W; Wang J
    Comb Chem High Throughput Screen; 2009 Jun; 12(5):497-506. PubMed ID: 19519329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of ADMET properties: how far have we come?
    Dearden JC
    Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):635-9. PubMed ID: 17916052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data.
    Legehar A; Xhaard H; Ghemtio L
    J Cheminform; 2016; 8():33. PubMed ID: 27303447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.